世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 卵巣癌治療薬の世界市場の洞察と2028年までの予測Global Ovarian Cancer Drugs Market Insights and Forecast to 2028 卵巣がんは、女性のがんの中で最も多いがんの一つとされています。女性の生殖器系のがんの中では最も死亡者数が多く、女性のがんによる死亡者数では第5位となっています。この種のがんは、早期に診断されることが... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー卵巣がんは、女性のがんの中で最も多いがんの一つとされています。女性の生殖器系のがんの中では最も死亡者数が多く、女性のがんによる死亡者数では第5位となっています。この種のがんは、早期に診断されることが少なく、進行した段階での治療が困難です。市場分析と洞察。世界の卵巣がん治療薬市場 COVID-19のパンデミックにより、卵巣がん治療薬の世界市場規模は2022年には百万米ドルと推定され、検討期間中のCAGRは%で2028年には百万米ドルに再調整されると予測されています。この健康危機による経済的変化を十分に考慮し、2021年に卵巣癌治療薬の世界市場の％を占めていた外科は、COVID-19以降の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、病院のセグメントは、この予測期間中、年率％で変化しています。 中国の卵巣癌治療薬の市場規模は2021年に百万米ドル、米国と欧州の卵巣癌治療薬の市場規模はそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には%ですが、中国とヨーロッパはそれぞれ%と%で、中国の割合は2028年には%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの卵巣がん治療薬市場では、ドイツが2028年までに100万米ドルに達すると予測されています。 卵巣癌治療薬の世界的な主要メーカーは、Bristol Myers Squibb、Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals、Novogen、Genentech、Aetera Zenteris、Boehringer Ingelheim、Rocheなどです。2021年には、世界の上位5社の売上高シェアは約%となっています。 世界の卵巣癌治療薬のスコープとセグメント 卵巣がん治療薬の市場は、タイプ別、アプリケーション別に分類されます。世界の卵巣がん治療薬市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。 タイプ別セグメント 手術療法 化学療法 放射線療法 生物学的療法 アプリケーション別 病院 クリニック その他 会社別 Bristol Myers Squibb イーライリリー グラクソ・スミスクライン（GlaxoSmithKline ヤンセン・ファーマシューティカルズ ノボジェン ジェネンテック エテラ・ゼンテリス ベーリンガーインゲルハイム（Boehringer Ingelheim ロシュ 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア U.A.E. 目次1 Study Coverage1.1 Ovarian Cancer Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Ovarian Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Surgery 1.2.3 Chemotherapy 1.2.4 Radiation 1.2.5 Biological Therapy 1.3 Market by Application 1.3.1 Global Ovarian Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Ovarian Cancer Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Ovarian Cancer Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Ovarian Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Ovarian Cancer Drugs Sales by Region 2.4.1 Global Ovarian Cancer Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Ovarian Cancer Drugs by Region (2023-2028) 2.5 Global Ovarian Cancer Drugs Revenue by Region 2.5.1 Global Ovarian Cancer Drugs Revenue by Region (2017-2022) 2.5.2 Global Ovarian Cancer Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Ovarian Cancer Drugs Sales by Manufacturers 3.1.1 Global Top Ovarian Cancer Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Ovarian Cancer Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ovarian Cancer Drugs in 2021 3.2 Global Ovarian Cancer Drugs Revenue by Manufacturers 3.2.1 Global Ovarian Cancer Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Ovarian Cancer Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Ovarian Cancer Drugs Revenue in 2021 3.3 Global Ovarian Cancer Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Ovarian Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Ovarian Cancer Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Ovarian Cancer Drugs Sales by Type 4.1.1 Global Ovarian Cancer Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Ovarian Cancer Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Ovarian Cancer Drugs Sales Market Share by Type (2017-2028) 4.2 Global Ovarian Cancer Drugs Revenue by Type 4.2.1 Global Ovarian Cancer Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Ovarian Cancer Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Ovarian Cancer Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Ovarian Cancer Drugs Price by Type 4.3.1 Global Ovarian Cancer Drugs Price by Type (2017-2022) 4.3.2 Global Ovarian Cancer Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Ovarian Cancer Drugs Sales by Application 5.1.1 Global Ovarian Cancer Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Ovarian Cancer Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Ovarian Cancer Drugs Sales Market Share by Application (2017-2028) 5.2 Global Ovarian Cancer Drugs Revenue by Application 5.2.1 Global Ovarian Cancer Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Ovarian Cancer Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Ovarian Cancer Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Ovarian Cancer Drugs Price by Application 5.3.1 Global Ovarian Cancer Drugs Price by Application (2017-2022) 5.3.2 Global Ovarian Cancer Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Ovarian Cancer Drugs Market Size by Type 6.1.1 North America Ovarian Cancer Drugs Sales by Type (2017-2028) 6.1.2 North America Ovarian Cancer Drugs Revenue by Type (2017-2028) 6.2 North America Ovarian Cancer Drugs Market Size by Application 6.2.1 North America Ovarian Cancer Drugs Sales by Application (2017-2028) 6.2.2 North America Ovarian Cancer Drugs Revenue by Application (2017-2028) 6.3 North America Ovarian Cancer Drugs Market Size by Country 6.3.1 North America Ovarian Cancer Drugs Sales by Country (2017-2028) 6.3.2 North America Ovarian Cancer Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Ovarian Cancer Drugs Market Size by Type 7.1.1 Europe Ovarian Cancer Drugs Sales by Type (2017-2028) 7.1.2 Europe Ovarian Cancer Drugs Revenue by Type (2017-2028) 7.2 Europe Ovarian Cancer Drugs Market Size by Application 7.2.1 Europe Ovarian Cancer Drugs Sales by Application (2017-2028) 7.2.2 Europe Ovarian Cancer Drugs Revenue by Application (2017-2028) 7.3 Europe Ovarian Cancer Drugs Market Size by Country 7.3.1 Europe Ovarian Cancer Drugs Sales by Country (2017-2028) 7.3.2 Europe Ovarian Cancer Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Ovarian Cancer Drugs Market Size by Type 8.1.1 Asia Pacific Ovarian Cancer Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Ovarian Cancer Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Ovarian Cancer Drugs Market Size by Application 8.2.1 Asia Pacific Ovarian Cancer Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Ovarian Cancer Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Ovarian Cancer Drugs Market Size by Region 8.3.1 Asia Pacific Ovarian Cancer Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Ovarian Cancer Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Ovarian Cancer Drugs Market Size by Type 9.1.1 Latin America Ovarian Cancer Drugs Sales by Type (2017-2028) 9.1.2 Latin America Ovarian Cancer Drugs Revenue by Type (2017-2028) 9.2 Latin America Ovarian Cancer Drugs Market Size by Application 9.2.1 Latin America Ovarian Cancer Drugs Sales by Application (2017-2028) 9.2.2 Latin America Ovarian Cancer Drugs Revenue by Application (2017-2028) 9.3 Latin America Ovarian Cancer Drugs Market Size by Country 9.3.1 Latin America Ovarian Cancer Drugs Sales by Country (2017-2028) 9.3.2 Latin America Ovarian Cancer Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Ovarian Cancer Drugs Market Size by Type 10.1.1 Middle East and Africa Ovarian Cancer Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Ovarian Cancer Drugs Market Size by Application 10.2.1 Middle East and Africa Ovarian Cancer Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Ovarian Cancer Drugs Market Size by Country 10.3.1 Middle East and Africa Ovarian Cancer Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Bristol Myers Squibb 11.1.1 Bristol Myers Squibb Corporation Information 11.1.2 Bristol Myers Squibb Overview 11.1.3 Bristol Myers Squibb Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bristol Myers Squibb Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bristol Myers Squibb Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Corporation Information 11.2.2 Eli Lilly Overview 11.2.3 Eli Lilly Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Overview 11.3.3 GlaxoSmithKline Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 GlaxoSmithKline Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 GlaxoSmithKline Recent Developments 11.4 Janssen Pharmaceuticals 11.4.1 Janssen Pharmaceuticals Corporation Information 11.4.2 Janssen Pharmaceuticals Overview 11.4.3 Janssen Pharmaceuticals Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Janssen Pharmaceuticals Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Janssen Pharmaceuticals Recent Developments 11.5 Novogen 11.5.1 Novogen Corporation Information 11.5.2 Novogen Overview 11.5.3 Novogen Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Novogen Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novogen Recent Developments 11.6 Genentech 11.6.1 Genentech Corporation Information 11.6.2 Genentech Overview 11.6.3 Genentech Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Genentech Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Genentech Recent Developments 11.7 Aetera Zenteris 11.7.1 Aetera Zenteris Corporation Information 11.7.2 Aetera Zenteris Overview 11.7.3 Aetera Zenteris Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Aetera Zenteris Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Aetera Zenteris Recent Developments 11.8 Boehringer Ingelheim 11.8.1 Boehringer Ingelheim Corporation Information 11.8.2 Boehringer Ingelheim Overview 11.8.3 Boehringer Ingelheim Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Boehringer Ingelheim Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Boehringer Ingelheim Recent Developments 11.9 Roche 11.9.1 Roche Corporation Information 11.9.2 Roche Overview 11.9.3 Roche Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Roche Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Roche Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Ovarian Cancer Drugs Industry Chain Analysis 12.2 Ovarian Cancer Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Ovarian Cancer Drugs Production Mode & Process 12.4 Ovarian Cancer Drugs Sales and Marketing 12.4.1 Ovarian Cancer Drugs Sales Channels 12.4.2 Ovarian Cancer Drugs Distributors 12.5 Ovarian Cancer Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Ovarian Cancer Drugs Industry Trends 13.2 Ovarian Cancer Drugs Market Drivers 13.3 Ovarian Cancer Drugs Market Challenges 13.4 Ovarian Cancer Drugs Market Restraints 14 Key Findings in The Global Ovarian Cancer Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryOvarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment at an advanced stage difficult. Table of Contents1 Study Coverage1.1 Ovarian Cancer Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Ovarian Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Surgery 1.2.3 Chemotherapy 1.2.4 Radiation 1.2.5 Biological Therapy 1.3 Market by Application 1.3.1 Global Ovarian Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Ovarian Cancer Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Ovarian Cancer Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Ovarian Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Ovarian Cancer Drugs Sales by Region 2.4.1 Global Ovarian Cancer Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Ovarian Cancer Drugs by Region (2023-2028) 2.5 Global Ovarian Cancer Drugs Revenue by Region 2.5.1 Global Ovarian Cancer Drugs Revenue by Region (2017-2022) 2.5.2 Global Ovarian Cancer Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Ovarian Cancer Drugs Sales by Manufacturers 3.1.1 Global Top Ovarian Cancer Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Ovarian Cancer Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ovarian Cancer Drugs in 2021 3.2 Global Ovarian Cancer Drugs Revenue by Manufacturers 3.2.1 Global Ovarian Cancer Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Ovarian Cancer Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Ovarian Cancer Drugs Revenue in 2021 3.3 Global Ovarian Cancer Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Ovarian Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Ovarian Cancer Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Ovarian Cancer Drugs Sales by Type 4.1.1 Global Ovarian Cancer Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Ovarian Cancer Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Ovarian Cancer Drugs Sales Market Share by Type (2017-2028) 4.2 Global Ovarian Cancer Drugs Revenue by Type 4.2.1 Global Ovarian Cancer Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Ovarian Cancer Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Ovarian Cancer Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Ovarian Cancer Drugs Price by Type 4.3.1 Global Ovarian Cancer Drugs Price by Type (2017-2022) 4.3.2 Global Ovarian Cancer Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Ovarian Cancer Drugs Sales by Application 5.1.1 Global Ovarian Cancer Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Ovarian Cancer Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Ovarian Cancer Drugs Sales Market Share by Application (2017-2028) 5.2 Global Ovarian Cancer Drugs Revenue by Application 5.2.1 Global Ovarian Cancer Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Ovarian Cancer Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Ovarian Cancer Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Ovarian Cancer Drugs Price by Application 5.3.1 Global Ovarian Cancer Drugs Price by Application (2017-2022) 5.3.2 Global Ovarian Cancer Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Ovarian Cancer Drugs Market Size by Type 6.1.1 North America Ovarian Cancer Drugs Sales by Type (2017-2028) 6.1.2 North America Ovarian Cancer Drugs Revenue by Type (2017-2028) 6.2 North America Ovarian Cancer Drugs Market Size by Application 6.2.1 North America Ovarian Cancer Drugs Sales by Application (2017-2028) 6.2.2 North America Ovarian Cancer Drugs Revenue by Application (2017-2028) 6.3 North America Ovarian Cancer Drugs Market Size by Country 6.3.1 North America Ovarian Cancer Drugs Sales by Country (2017-2028) 6.3.2 North America Ovarian Cancer Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Ovarian Cancer Drugs Market Size by Type 7.1.1 Europe Ovarian Cancer Drugs Sales by Type (2017-2028) 7.1.2 Europe Ovarian Cancer Drugs Revenue by Type (2017-2028) 7.2 Europe Ovarian Cancer Drugs Market Size by Application 7.2.1 Europe Ovarian Cancer Drugs Sales by Application (2017-2028) 7.2.2 Europe Ovarian Cancer Drugs Revenue by Application (2017-2028) 7.3 Europe Ovarian Cancer Drugs Market Size by Country 7.3.1 Europe Ovarian Cancer Drugs Sales by Country (2017-2028) 7.3.2 Europe Ovarian Cancer Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Ovarian Cancer Drugs Market Size by Type 8.1.1 Asia Pacific Ovarian Cancer Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Ovarian Cancer Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Ovarian Cancer Drugs Market Size by Application 8.2.1 Asia Pacific Ovarian Cancer Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Ovarian Cancer Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Ovarian Cancer Drugs Market Size by Region 8.3.1 Asia Pacific Ovarian Cancer Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Ovarian Cancer Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Ovarian Cancer Drugs Market Size by Type 9.1.1 Latin America Ovarian Cancer Drugs Sales by Type (2017-2028) 9.1.2 Latin America Ovarian Cancer Drugs Revenue by Type (2017-2028) 9.2 Latin America Ovarian Cancer Drugs Market Size by Application 9.2.1 Latin America Ovarian Cancer Drugs Sales by Application (2017-2028) 9.2.2 Latin America Ovarian Cancer Drugs Revenue by Application (2017-2028) 9.3 Latin America Ovarian Cancer Drugs Market Size by Country 9.3.1 Latin America Ovarian Cancer Drugs Sales by Country (2017-2028) 9.3.2 Latin America Ovarian Cancer Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Ovarian Cancer Drugs Market Size by Type 10.1.1 Middle East and Africa Ovarian Cancer Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Ovarian Cancer Drugs Market Size by Application 10.2.1 Middle East and Africa Ovarian Cancer Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Ovarian Cancer Drugs Market Size by Country 10.3.1 Middle East and Africa Ovarian Cancer Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Ovarian Cancer Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Bristol Myers Squibb 11.1.1 Bristol Myers Squibb Corporation Information 11.1.2 Bristol Myers Squibb Overview 11.1.3 Bristol Myers Squibb Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bristol Myers Squibb Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bristol Myers Squibb Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Corporation Information 11.2.2 Eli Lilly Overview 11.2.3 Eli Lilly Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Overview 11.3.3 GlaxoSmithKline Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 GlaxoSmithKline Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 GlaxoSmithKline Recent Developments 11.4 Janssen Pharmaceuticals 11.4.1 Janssen Pharmaceuticals Corporation Information 11.4.2 Janssen Pharmaceuticals Overview 11.4.3 Janssen Pharmaceuticals Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Janssen Pharmaceuticals Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Janssen Pharmaceuticals Recent Developments 11.5 Novogen 11.5.1 Novogen Corporation Information 11.5.2 Novogen Overview 11.5.3 Novogen Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Novogen Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novogen Recent Developments 11.6 Genentech 11.6.1 Genentech Corporation Information 11.6.2 Genentech Overview 11.6.3 Genentech Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Genentech Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Genentech Recent Developments 11.7 Aetera Zenteris 11.7.1 Aetera Zenteris Corporation Information 11.7.2 Aetera Zenteris Overview 11.7.3 Aetera Zenteris Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Aetera Zenteris Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Aetera Zenteris Recent Developments 11.8 Boehringer Ingelheim 11.8.1 Boehringer Ingelheim Corporation Information 11.8.2 Boehringer Ingelheim Overview 11.8.3 Boehringer Ingelheim Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Boehringer Ingelheim Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Boehringer Ingelheim Recent Developments 11.9 Roche 11.9.1 Roche Corporation Information 11.9.2 Roche Overview 11.9.3 Roche Ovarian Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Roche Ovarian Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Roche Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Ovarian Cancer Drugs Industry Chain Analysis 12.2 Ovarian Cancer Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Ovarian Cancer Drugs Production Mode & Process 12.4 Ovarian Cancer Drugs Sales and Marketing 12.4.1 Ovarian Cancer Drugs Sales Channels 12.4.2 Ovarian Cancer Drugs Distributors 12.5 Ovarian Cancer Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Ovarian Cancer Drugs Industry Trends 13.2 Ovarian Cancer Drugs Market Drivers 13.3 Ovarian Cancer Drugs Market Challenges 13.4 Ovarian Cancer Drugs Market Restraints 14 Key Findings in The Global Ovarian Cancer Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（ovarian cancer）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
